Apoptosis mediated by phosphatidylcholine-specific phospholipase C is associated with cAMP, p53 level, and cell-cycle distribution in vascular endothelial cells.
D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D001952:Bridged-Ring Compounds / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects / Q000235:genetics; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005346:Fibroblast Growth Factors / Q000172:deficiency; D006801:Humans; D007424:Intracellular Fluid / Q000187:drug effects / Q000378:metabolism; D009636:Norbornanes; D010766:Phosphorylation / Q000187:drug effects; D013859:Thiocarbamates; D013871:Thiones / Q000494:pharmacology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors / Q000378:metabolism*
D001952:Bridged-Ring Compounds; D016895:Culture Media, Serum-Free; D004791:Enzyme Inhibitors; D009636:Norbornanes; D013859:Thiocarbamates; D013871:Thiones; D016159:Tumor Suppressor Protein p53; C046498:tricyclodecane-9-yl-xanthogenate; D005346:Fibroblast Growth Factors; D000242:Cyclic AMP; D010738:Type C Phospholipases; C105598:phosphatidylcholine-specific phospholipase C